New and exciting opportunities to enhance diversity and inclusion in clinical trial populations have arrived. In particular, novel digital health technologies (DHTs), which — when carefully designed and prudently implemented — are sure to make significant strides towards achieving the promise of more inclusive clinical trials. Yet in order to achieve success, Designing for Diversity requires an extraordinary degree of planning and sophistication.
Learn more by reading this White Paper by IQVIA experts Tapan Raval and Ashley Polhemus.
Fast, flexible and proven, IQVIA’s industry-leading electronic clinical outcome assessment (eCOA) platform ramps up efficiencies, delivers real-time data, and sharpens insights through best-in-class technology and a better patient experience.
.svg){kind=icon}
